Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-26-003608
Filing Date
2026-01-26
Accepted
2026-01-26 16:31:17
Documents
2
Period of Report
2026-01-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 3668
2 EX-24 ex24.htm EX-24 24994
  Complete submission text file 0001493152-26-003608.txt   30390
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6555 CARNEGIE AVENUE FLOOR 4 CLEVELAND OH 44103
Business Address
Vasanthavada Madhav (Reporting) CIK: 0002106295 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 26560883